Semi-allogeneic cell hybrids stimulate HIV-1 envelope-specific cytotoxic T lymphocytes

AIDS

Volumn 14, Issue 11, 2000, Pages 1497-1506

  Grene, Edith ^a   Newton, Danforth A ^b   Brown, Edwin A ^b   Berzofsky, Jay A ^a   Gattoni Celli, Sebastiano ^b   Shearer, Gene M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Antigen presenting cells; Cytotoxic T lymphocytes; HIV infection; T helper cells

Indexed keywords

CD86 ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INDINAVIR; LAMIVUDINE; NELFINAVIR; VIRUS ENVELOPE PROTEIN; VIRUS RNA; ZIDOVUDINE;

ALLOIMMUNIZATION; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYBRID CELL; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MONONUCLEAR CELL; PRIORITY JOURNAL;

HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP160; HIV INFECTIONS; HIV-1; HUMANS; HYBRID CELLS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0033811240     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200007280-00005     Document Type: Article

References (30)

1. Alloimmunization for immunebased therapy and vaccine design against HIV/AIDS
2. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy HAART) in patients with a history of sustained viral suppression
3. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging
4. Circumvention of defective CD4 T helper cell function in HIV-infected individuals by stimulation with HLA alloantigens
5. HIV-induced immunopathogenesis
6. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes
7. Helper-CTL determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs
8. Enhanced immunogenicity of HIV-1 vaccine construct by modification of the native peptide sequence
9. Irradiated semi-allogeneic cell hybrids as therapeutic vaccines for cancer
10. Tumor-specific immunity induced by somatic hybrids. II. Elicitation of enhanced immunity against parent plasmacytoma
11. Adoptive transfer of immunity induced by semi-allogeneic hybrid cells, against a murine fibrosarcoma
12. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids
13. Human neoplastic and normal cells in tissue culture I. Cell lines derived from malignant melanomas and normal melanocytes
14. Biochemical transfer of single copy eucaryotic genes using total cellular DNA as donor
15. High efficiency DNA-mediated transfor-mation of primate cells
16. Antibodies to major histocompatibility antigens produced by hybrid cell lines
17. Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using 16-residue synthetic peptide
18. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes
19. T cell multideterminal regions in the human immunodeficiency virus envelope: Towards overcoming the problem of major histocompatibility complex restriction
20. Antigenic peptides recognized by T helper lymphocytes from asymptomatic, HIV seropositire individuals
21. HIV-specific immunity following immunization with HIV synthetic envelope peptides in asymptomatic HIV-infected patients
22. Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in 2m gene expression
23. Selective loss of human leukocyte class I allospecifities and staining of melanoma cells by monodonal antibodies recognizing monomorphic determinants of human leukocyte class I antigens
24. Effect of irradiation on cytokine production, MHC antigen expression, and vaccine potential of interleukin-2 and interferon-gamma gene-modified melanoma cells
25. Vaccination with IL-12 gene-modified autologous melanoma cells: Preclinical results and a first clinical phase I study
26. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia
27. Use of intrinsic and extrinsic helper epitopes for in vitro induction of anti-Hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines
28. Monocytes in HIV type 1-infected individuals lose expression of costimulatory B7 molecules and acquire cytotoxic activity
29. Induction of HIV-1 replication by allogeneic stimulation
30. Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients